Vascular embolization refers to a minimally invasive medical procedure that occludes or blocks blood vessels. It utilizes embolic agents such as coils, vascular plugs, liquid embolics, and beads to obstruct blood flow in diseased blood vessels to treat various medical conditions such as hemorrhage, tumors and arteriovenous malformations. Vascular embolization provides benefits such as reduced trauma, faster recovery time and minimal scarring compared to traditional open surgeries. Growing prevalence of neurological, oncological and urological disorders increases the demand for vascular embolization procedures.
The global Vascular Embolization Market is estimated to be valued at US$ 1809.45 Mn in 2023 and is expected to exhibit a CAGR of 9.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
Advancements in embolization techniques present a lucrative opportunity for substantial growth of the vascular embolization market. Significant improvements have been made in coil, plug and liquid embolization technologies toenhance precision and efficacy of treatment. Technological upgrades including use of bioactive coils and plugs coated with drugs and nanomedicines are being developed to more effectively treat complex vascular anomalies. Additionally, novel procedures like using drug-eluting microspheres for localized drug delivery in tumors shows promise. Continuous R&D aimed at developing advanced customized embolization solutions tailored for specific indications will drive the demand over the forecast period.
Porter's Analysis
Threat of new entrants: Low due to high capital required for R&D and manufacturing, established brand names of existing players, and stringent regulations.
Bargaining power of buyers: Moderate as buyers have alternatives but high importance of healthcare drives customer loyalty.
Bargaining power of suppliers: Moderate as suppliers have variability in raw materials and specifications required.
Threat of new substitutes: Low as procedure needed is specialized requiring expertise and technology not easily replaced.
Competitive rivalry: High owing to frequent new product launches, acquisitions and strong focus on innovation.
SWOT Analysis
Strengths: Rapidly growing minimally invasive procedures, rising favorable reimbursements and guidelines.
Weaknesses: High cost of treatment, lack of skilled professionals in developing regions.
Opportunities: Untapped potential in emerging economies, scope for improving product efficacy.
Threats: Risks associated with procedures, pricing pressure from generic alternatives.
Key Takeaways
The Global Vascular Embolization Market Demand is expected to witness high growth during the forecast period of 2023 to 2030. The North America region currently dominates due to rapid adoption of new technologies and demand for minimally invasive surgeries.
Regionally, Asia Pacific is poised to grow at the fastest pace over the coming years. Emerging countries like India, China and Japan are witnessing an increasing patient pool suffering from target diseases on the back of rapidly aging population and lifestyles changes.
Key players operating in the vascular embolization market are Shape Memory Medical Inc., Terumo Corp, Penumbra Inc., Abbott Laboratories, Stryker Corporation, Cook Medical, Medtronic PLC, Merit Medical Systems Inc., Johnson and Johnson (Cerenovus), and Boston Scientific Corporation, among others. There is strong competition between market leaders focused on expanding their product suites and geographical footprints through strategic acquisitions and new product approvals.
Explore more information on this topic, Please visit @ https://www.rapidwebwire.com/flourished-by-rising-demand-for-minimally-invasive-procedures-share
Comments
0 comment